Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Plasma cell 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Ovarian Neoplasms 3Neoplasms 3Stomach Neoplasms 1Sarcoma, Endometrial Stromal 1Sarcoma 1Rhabdomyosarcoma 1Pancreatic Neoplasms 1Neoplasms, Plasma Cell 1Lung Neoplasms 1Liver Neoplasms 1Liposarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Fibrosarcoma 1Fallopian Tube Neoplasms 1Dermatofibrosarcoma 1Colonic Neoplasms 1Choriocarcinoma 1Cholangiocarcinoma 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Flow Cytometry 3Methylprednisolone 2Immunologic Techniques 2Alemtuzumab 2sargramostim 1saracatinib 1resiquimod 1poly ICLC 1pembrolizumab 1liposomal doxorubicin 1dexamethasone acetate 1dexamethasone 21-phosphate 1cediranib 1aldesleukin 1Therapeutics 1Tacrolimus 1Psychiatric Rehabilitation 1Prednisone 1Moxifloxacin 1Microarray Analysis 1Interleukin-12 Subunit p35 1Interferon-alpha 1Immunoenzyme Techniques 1Granisetron 1Gene Expression Profiling 1ER 30346 1Dexamethasone 1Deferasirox 1Data Collection 1Dalteparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Plasma Cell × saracatinib × Gynecologic × Clear all
NCT00475956 2010-04-15

Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours

AstraZeneca

Phase 1 Completed
40 enrolled
BreastGastrointestinalGynecologicPlasma cellThoracic

Breast Neoplasms, Choriocarcinoma, Colonic Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Cholangiocarcinoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡